secret_name;covid19_date_reporting;covid19_has_symptoms;covid19_sympt_fever;covid19_sympt_dry_cough;covid19_sympt_fatigue;covid19_sympt_pain;covid19_sympt_sore_throat;covid19_sympt_shortness_breath;covid19_sympt_nasal_congestion;covid19_sympt_chills;covid19_sympt_loss_smell_taste;covid19_sympt_pneumonia;covid19_suspected_case;covid19_self_isolation;covid19_self_isolation_by_self_patient;covid19_self_isolation_date;covid19_self_isolation_duration;covid19_confirmed_case;covid19_date_lab_test;covid19_country;covid19_date_suspected_onset;covid19_admission_hospital;covid19_admission_hospital_date;covid19_admission_hospital_release;covid19_icu_stay;covid19_still_icu_stay;covid19_icu_current_duration;covid19_icu_total_duration;covid19_ventilation;covid19_ventilation_non_invasive;covid19_ventilation_invasive;covid19_ecmo;covid19_outcome_recovered;covid19_outcome_death;covid19_outcome_death_date;age_years;sex;pregnancy;current_smoker;former_smoker;height;weight;is_healthcare_profession;ms_type;ms_onset_date;ms_diagnosis_date;edss_date_diagnosis;edss_value;last_white_blood_cell;last_white_blood_cell_unit;last_lympho_cell;last_lympho_cell_unit;last_b_cell;last_b_cell_unit;current_dmt;type_dmt;type_dmt_other;dmt_start_date;dmt_end_date;dmt_stop_date;dmt_stop_reason;dmt_glucocorticoid;dmt_glucocorticoid_start_date;dmt_glucocorticoid_stop_date;dmt_glucocorticoid_dosage_value;dmt_glucocorticoid_dosage_unit;has_comorbidities;com_cardiovascular_disease;com_hypertension;com_diabetes;com_chronic_liver_disease;com_chronic_kidney_disease;com_neurological_neuromuscular;com_lung_disease;com_immunodeficiency;com_malignancy;com_otherPREFIX_FMBGG/1;15/05/1983;yes;no;no;no;yes;no;yes;;yes;no;yes;no;no;yes;15/05/1983;8.96;yes;15/05/1983;example content;19/02/2013;no;;19/02/2013;no;yes;;;yes;no;no;yes;not_applicable;yes;12/05/2017;200.0;non-binary;;no;no;15.23;1.236;yes;CIS;15/05/1983;15/05/1983;15/05/1983;8.96;170.25;lorem ipsum;8.96;lorem ipsum;170.25;example text;never_treated;interferons;lorem ipsum;16/10/2019;15/05/1983;19/02/2013;onset_covid;yes;;19/02/2013;;example content;no;yes;yes;no;yes;no;no;no;no;no;PREFIX_KWKYT/1;16/10/2019;no;yes;yes;no;yes;no;yes;;yes;no;yes;yes;no;yes;16/10/2019;;no;05/12/2017;;16/10/2019;no;;12/05/2017;no;no;170.25;;yes;yes;yes;no;yes;no;15/05/1983;160.23;female;no;yes;no;8.96;;yes;CIS;05/12/2017;19/02/2013;05/12/2017;1.236;160.23;example content;170.25;example content;170.25;example text;yes;interferons;example text;16/10/2019;15/05/1983;19/02/2013;onset_covid;no;16/10/2019;12/05/2017;15.23;lorem ipsum;yes;no;no;no;no;no;yes;yes;no;yes;PREFIX_BOUNF/1;05/12/2017;no;no;yes;yes;yes;no;no;yes;;yes;no;;yes;;19/02/2013;7.78;no;15/05/1983;example text;19/02/2013;;;16/10/2019;no;no;15.23;;yes;yes;yes;;no;no;15/05/1983;170.25;male;no;yes;yes;15.23;170.25;yes;CIS;15/05/1983;19/02/2013;;1.236;7.78;lorem ipsum;170.25;example content;160.23;example text;yes;cladribine;lorem ipsum;05/12/2017;;19/02/2013;adverse_event;yes;12/05/2017;19/02/2013;7.78;example text;no;yes;yes;yes;yes;yes;yes;yes;no;yes;example contentPREFIX_FUJYX/1;15/05/1983;no;no;yes;no;yes;no;yes;yes;yes;yes;yes;no;;yes;19/02/2013;7.78;no;15/05/1983;example content;19/02/2013;no;;15/05/1983;yes;yes;170.25;1.236;no;yes;yes;yes;no;yes;12/05/2017;7.78;male;no;yes;no;15.23;7.78;;PPMS;;15/05/1983;19/02/2013;1.236;170.25;example text;;example content;7.78;example content;no;teriflunomide;example content;;15/05/1983;19/02/2013;patient_decision;yes;;16/10/2019;15.23;example content;no;yes;yes;no;;no;yes;yes;yes;no;example textPREFIX_IUGSA/1;16/10/2019;no;yes;;yes;no;yes;no;no;yes;no;yes;no;no;yes;;;yes;19/02/2013;example content;;no;;16/10/2019;no;yes;1.236;1.236;no;no;yes;yes;not_applicable;yes;;8.96;male;;;yes;1.236;15.23;yes;not_sure;05/12/2017;;19/02/2013;;160.23;example text;8.96;example content;170.25;example text;yes;teriflunomide;example content;05/12/2017;15/05/1983;;patient_decision;;16/10/2019;12/05/2017;8.96;example content;yes;no;no;yes;no;yes;no;no;yes;yes;example textPREFIX_ULRAP/1;15/05/1983;yes;no;yes;yes;no;yes;no;yes;yes;;yes;no;yes;no;19/02/2013;8.96;yes;05/12/2017;example text;;yes;16/10/2019;16/10/2019;yes;no;1.236;8.96;yes;yes;yes;yes;no;no;19/02/2013;;female;yes;yes;yes;160.23;15.23;yes;SPMS;16/10/2019;16/10/2019;16/10/2019;8.96;1.236;lorem ipsum;160.23;;7.78;example content;never_treated;cladribine;;05/12/2017;19/02/2013;19/02/2013;;yes;15/05/1983;16/10/2019;15.23;example text;no;no;no;yes;yes;yes;;yes;no;no;example textPREFIX_SHCAO/1;05/12/2017;no;yes;no;yes;no;yes;no;yes;no;no;no;yes;yes;no;16/10/2019;15.23;yes;;example content;;yes;;15/05/1983;yes;yes;;1.236;yes;yes;no;yes;yes;yes;16/10/2019;8.96;male;no;no;no;1.236;;no;CIS;05/12/2017;16/10/2019;16/10/2019;1.236;7.78;lorem ipsum;170.25;lorem ipsum;8.96;example text;never_treated;fingolimod;lorem ipsum;16/10/2019;16/10/2019;15/05/1983;patient_decision;;16/10/2019;12/05/2017;160.23;lorem ipsum;no;yes;;yes;yes;yes;yes;yes;yes;;example contentPREFIX_UNGSF/1;19/02/2013;no;yes;yes;no;;no;yes;;no;;yes;yes;no;no;15/05/1983;7.78;;05/12/2017;example text;15/05/1983;no;05/12/2017;16/10/2019;no;no;15.23;160.23;yes;yes;;yes;no;;19/02/2013;7.78;male;yes;yes;no;;15.23;no;not_sure;19/02/2013;;;8.96;7.78;lorem ipsum;1.236;example text;170.25;example content;never_treated;cladribine;example text;05/12/2017;05/12/2017;16/10/2019;pregnancy;no;;12/05/2017;160.23;lorem ipsum;no;yes;no;no;yes;yes;yes;yes;yes;yes;lorem ipsumPREFIX_XOJVL/1;05/12/2017;yes;no;yes;no;no;no;no;yes;;yes;yes;yes;yes;no;;7.78;;15/05/1983;;19/02/2013;;15/05/1983;19/02/2013;no;no;170.25;160.23;;yes;no;yes;not_applicable;no;16/10/2019;15.23;male;yes;no;yes;15.23;160.23;yes;SPMS;15/05/1983;16/10/2019;15/05/1983;160.23;160.23;example text;170.25;example text;170.25;example content;no;siponimod;lorem ipsum;15/05/1983;19/02/2013;15/05/1983;adverse_event;no;19/02/2013;19/02/2013;160.23;example text;yes;yes;yes;;no;;no;;no;yes;lorem ipsum;16/10/2019;no;yes;yes;yes;no;yes;;no;yes;no;no;;no;no;19/02/2013;;yes;05/12/2017;lorem ipsum;05/12/2017;yes;16/10/2019;12/05/2017;no;no;7.78;160.23;yes;yes;yes;yes;not_applicable;yes;19/02/2013;160.23;male;no;no;no;160.23;170.25;no;PPMS;05/12/2017;05/12/2017;19/02/2013;1.236;1.236;example text;1.236;example text;160.23;example text;never_treated;teriflunomide;lorem ipsum;16/10/2019;;16/10/2019;onset_covid;yes;12/05/2017;12/05/2017;7.78;example text;yes;yes;yes;yes;yes;no;yes;no;no;yes;lorem ipsumPREFIX_DEXVM/1;05/12/2017;no;no;;no;yes;no;yes;no;no;no;no;yes;yes;no;;8.96;no;;example content;16/10/2019;no;05/12/2017;12/05/2017;;no;8.96;160.23;yes;no;;no;no;no;19/02/2013;8.96;male;;yes;no;8.96;1.236;;SPMS;;05/12/2017;16/10/2019;7.78;7.78;example content;170.25;example text;1.236;example content;never_treated;siponimod;example content;05/12/2017;;16/10/2019;adverse_event;no;15/05/1983;19/02/2013;160.23;example content;yes;no;yes;no;yes;yes;no;yes;yes;no;example textPREFIX_FLOPC/1;;yes;;yes;no;yes;yes;yes;no;no;yes;no;yes;yes;no;;1.236;;05/12/2017;lorem ipsum;15/05/1983;yes;;;;no;170.25;1.236;no;yes;no;no;not_applicable;yes;16/10/2019;7.78;female;no;no;yes;8.96;160.23;yes;;19/02/2013;05/12/2017;05/12/2017;15.23;160.23;example text;;example text;170.25;;;rituximab;lorem ipsum;19/02/2013;16/10/2019;15/05/1983;;no;12/05/2017;;15.23;example content;yes;no;yes;yes;yes;yes;no;no;yes;yes;example contentPREFIX_YEEZT/1;16/10/2019;yes;;yes;;no;no;no;no;;yes;no;yes;yes;;16/10/2019;170.25;yes;15/05/1983;example text;15/05/1983;yes;19/02/2013;;yes;no;1.236;1.236;no;yes;no;yes;not_applicable;no;15/05/1983;15.23;male;no;no;;7.78;7.78;no;not_sure;;05/12/2017;15/05/1983;15.23;8.96;lorem ipsum;;lorem ipsum;;example content;never_treated;cladribine;example content;19/02/2013;15/05/1983;;onset_covid;no;15/05/1983;15/05/1983;15.23;lorem ipsum;no;no;no;no;no;yes;yes;yes;yes;no;lorem ipsumPREFIX_CCLKS/1;;yes;no;;no;no;yes;no;no;no;no;no;yes;;yes;16/10/2019;170.25;no;05/12/2017;;05/12/2017;yes;05/12/2017;19/02/2013;no;no;15.23;170.25;no;no;no;no;;;12/05/2017;;female;no;yes;no;170.25;170.25;yes;;15/05/1983;05/12/2017;16/10/2019;160.23;8.96;lorem ipsum;160.23;lorem ipsum;8.96;example text;never_treated;natalizumab;example content;16/10/2019;19/02/2013;19/02/2013;lack_efficacy;no;16/10/2019;;1.236;example text;no;no;yes;no;yes;;yes;no;yes;yes;example contentPREFIX_MIDOH/1;15/05/1983;no;no;yes;;no;yes;yes;yes;no;no;yes;yes;no;yes;15/05/1983;8.96;no;15/05/1983;lorem ipsum;19/02/2013;yes;19/02/2013;;yes;yes;170.25;8.96;no;no;no;no;yes;no;16/10/2019;;non-binary;no;no;yes;15.23;170.25;yes;SPMS;16/10/2019;15/05/1983;19/02/2013;15.23;1.236;example text;8.96;example text;1.236;example content;yes;teriflunomide;example content;16/10/2019;16/10/2019;16/10/2019;pregnancy;yes;;16/10/2019;160.23;example text;no;no;no;no;;yes;no;no;yes;no;example textPREFIX_QMEUP/1;15/05/1983;yes;yes;yes;yes;no;no;no;no;no;no;no;yes;no;;12/05/2017;170.25;no;15/05/1983;lorem ipsum;16/10/2019;yes;15/05/1983;19/02/2013;no;no;;8.96;yes;no;no;no;no;no;12/05/2017;7.78;;yes;yes;;8.96;;no;SPMS;05/12/2017;05/12/2017;19/02/2013;1.236;160.23;example content;170.25;example text;170.25;example content;never_treated;teriflunomide;example text;19/02/2013;19/02/2013;15/05/1983;patient_decision;;12/05/2017;15/05/1983;;example text;yes;no;yes;;yes;no;no;yes;yes;yes;example textPREFIX_LBSTW/1;19/02/2013;no;yes;yes;yes;no;no;yes;yes;yes;;no;yes;no;no;;8.96;yes;16/10/2019;example content;05/12/2017;no;16/10/2019;12/05/2017;no;no;15.23;;no;yes;no;;yes;yes;12/05/2017;1.236;non-binary;;no;no;8.96;1.236;yes;SPMS;05/12/2017;19/02/2013;19/02/2013;;;example content;1.236;lorem ipsum;15.23;example text;never_treated;rituximab;;16/10/2019;05/12/2017;15/05/1983;patient_decision;yes;15/05/1983;15/05/1983;15.23;example content;;no;yes;no;no;yes;yes;no;yes;yes;example textPREFIX_YEEBJ/1;16/10/2019;no;no;yes;no;no;yes;yes;yes;no;;;yes;no;no;12/05/2017;8.96;no;16/10/2019;example text;15/05/1983;yes;15/05/1983;19/02/2013;no;;1.236;7.78;yes;yes;no;no;no;yes;;160.23;male;no;no;;8.96;160.23;no;not_sure;19/02/2013;16/10/2019;05/12/2017;7.78;8.96;example text;170.25;example text;15.23;example content;yes;cladribine;example text;19/02/2013;15/05/1983;19/02/2013;;no;19/02/2013;;160.23;example content;no;no;no;no;no;no;yes;yes;;yes;example textPREFIX_PDRVK/1;05/12/2017;yes;no;yes;no;;;no;;yes;;no;no;no;no;16/10/2019;170.25;;19/02/2013;example content;05/12/2017;yes;19/02/2013;;yes;no;8.96;7.78;;;no;no;no;yes;15/05/1983;7.78;female;yes;yes;no;1.236;160.23;;RRMS;05/12/2017;15/05/1983;16/10/2019;160.23;1.236;example text;160.23;example content;1.236;example content;;rituximab;lorem ipsum;05/12/2017;16/10/2019;19/02/2013;adverse_event;no;15/05/1983;16/10/2019;8.96;lorem ipsum;no;yes;yes;yes;;no;no;yes;;no;example content;19/02/2013;yes;no;no;yes;no;no;yes;yes;;yes;;yes;yes;yes;16/10/2019;7.78;yes;05/12/2017;example text;19/02/2013;yes;19/02/2013;12/05/2017;no;yes;7.78;7.78;no;yes;no;no;;yes;15/05/1983;1.236;non-binary;yes;yes;;170.25;7.78;;SPMS;16/10/2019;19/02/2013;19/02/2013;8.96;15.23;example text;;;7.78;example text;never_treated;cladribine;example content;05/12/2017;16/10/2019;19/02/2013;lack_efficacy;;16/10/2019;12/05/2017;;lorem ipsum;;yes;no;yes;no;no;yes;yes;no;yes;example textPREFIX_ORQQH/1;16/10/2019;no;yes;;;no;yes;no;;yes;yes;yes;yes;no;yes;;8.96;;05/12/2017;example content;05/12/2017;no;05/12/2017;16/10/2019;yes;;;8.96;yes;yes;yes;yes;yes;yes;;170.25;male;yes;no;yes;15.23;;;CIS;05/12/2017;19/02/2013;19/02/2013;7.78;8.96;lorem ipsum;160.23;example text;;example text;no;;lorem ipsum;15/05/1983;15/05/1983;05/12/2017;onset_covid;no;;15/05/1983;1.236;lorem ipsum;yes;no;yes;no;yes;no;no;yes;yes;yes;example contentPREFIX_CCZUJ/1;15/05/1983;no;yes;yes;yes;no;no;yes;no;no;no;yes;no;no;yes;15/05/1983;1.236;no;15/05/1983;lorem ipsum;16/10/2019;no;19/02/2013;12/05/2017;yes;no;1.236;1.236;no;;no;no;not_applicable;yes;12/05/2017;7.78;;no;yes;no;8.96;7.78;;PPMS;16/10/2019;05/12/2017;15/05/1983;15.23;1.236;example text;15.23;example text;8.96;example content;no;interferons;example text;16/10/2019;;;pregnancy;no;16/10/2019;19/02/2013;170.25;;no;no;yes;;no;yes;yes;no;yes;no;lorem ipsumPREFIX_ODLNM/1;15/05/1983;yes;yes;no;;no;no;;yes;no;yes;yes;;yes;no;15/05/1983;7.78;yes;05/12/2017;lorem ipsum;05/12/2017;;05/12/2017;19/02/2013;yes;yes;170.25;7.78;no;no;yes;no;no;yes;19/02/2013;1.236;male;yes;no;no;160.23;1.236;yes;RRMS;19/02/2013;15/05/1983;19/02/2013;8.96;7.78;example text;1.236;lorem ipsum;1.236;example text;never_treated;cladribine;lorem ipsum;;19/02/2013;19/02/2013;lack_efficacy;yes;16/10/2019;19/02/2013;160.23;example content;no;no;no;yes;yes;no;no;yes;;yes;lorem ipsumPREFIX_VDSEC/1;19/02/2013;yes;yes;;yes;no;yes;no;yes;yes;yes;no;yes;yes;no;12/05/2017;170.25;no;15/05/1983;example content;05/12/2017;yes;05/12/2017;16/10/2019;no;yes;;1.236;no;;yes;yes;no;no;12/05/2017;170.25;female;yes;yes;no;;8.96;no;PPMS;05/12/2017;15/05/1983;05/12/2017;15.23;8.96;example text;170.25;example text;;example content;yes;cladribine;example content;15/05/1983;19/02/2013;05/12/2017;lack_efficacy;yes;;12/05/2017;160.23;example text;yes;;yes;no;no;yes;yes;;no;yes;example contentPREFIX_ZGZUJ/1;16/10/2019;no;yes;no;yes;no;;yes;yes;yes;no;no;no;yes;;15/05/1983;160.23;no;16/10/2019;example content;;;19/02/2013;12/05/2017;;yes;1.236;1.236;no;no;no;no;;no;19/02/2013;170.25;non-binary;no;yes;yes;;1.236;no;;19/02/2013;15/05/1983;15/05/1983;160.23;15.23;example text;160.23;example content;8.96;example text;yes;ocrelizumab;lorem ipsum;05/12/2017;15/05/1983;19/02/2013;patient_decision;yes;19/02/2013;16/10/2019;170.25;example content;yes;yes;no;no;no;yes;yes;yes;yes;no;lorem ipsumPREFIX_WELVY/1;05/12/2017;yes;yes;yes;no;no;yes;yes;yes;yes;yes;no;yes;yes;;19/02/2013;1.236;no;05/12/2017;lorem ipsum;19/02/2013;yes;16/10/2019;12/05/2017;yes;yes;160.23;170.25;;yes;yes;no;yes;yes;12/05/2017;7.78;non-binary;no;;yes;8.96;7.78;yes;;15/05/1983;19/02/2013;16/10/2019;8.96;8.96;example text;1.236;example text;1.236;example content;never_treated;fingolimod;example content;05/12/2017;16/10/2019;05/12/2017;adverse_event;no;19/02/2013;15/05/1983;160.23;example content;yes;;yes;;no;yes;yes;yes;;yes;PREFIX_GGZRK/1;15/05/1983;yes;yes;no;yes;no;no;no;yes;no;no;yes;yes;no;no;19/02/2013;7.78;yes;16/10/2019;example content;19/02/2013;yes;19/02/2013;19/02/2013;no;yes;8.96;170.25;yes;yes;no;no;not_applicable;no;19/02/2013;1.236;male;no;yes;yes;15.23;160.23;no;CIS;15/05/1983;16/10/2019;16/10/2019;8.96;170.25;example content;8.96;example content;8.96;example content;never_treated;rituximab;lorem ipsum;16/10/2019;05/12/2017;16/10/2019;adverse_event;yes;;;8.96;example text;yes;yes;no;no;yes;no;yes;no;no;yes;lorem ipsumPREFIX_GPHVI/1;16/10/2019;no;yes;no;no;yes;no;yes;no;no;yes;yes;;no;yes;19/02/2013;15.23;yes;15/05/1983;example content;16/10/2019;;;16/10/2019;yes;no;8.96;1.236;yes;yes;yes;yes;no;no;12/05/2017;7.78;non-binary;no;no;yes;15.23;15.23;no;PPMS;16/10/2019;19/02/2013;16/10/2019;8.96;15.23;example text;160.23;example content;15.23;lorem ipsum;yes;ocrelizumab;lorem ipsum;16/10/2019;16/10/2019;;;no;19/02/2013;19/02/2013;8.96;lorem ipsum;yes;yes;yes;yes;;no;no;yes;no;;lorem ipsumPREFIX_NLWQC/1;05/12/2017;yes;;no;yes;yes;yes;;;yes;no;yes;no;;;16/10/2019;7.78;;05/12/2017;example text;15/05/1983;yes;16/10/2019;19/02/2013;no;yes;1.236;170.25;yes;yes;yes;no;no;yes;19/02/2013;160.23;;no;no;no;1.236;170.25;;PPMS;05/12/2017;19/02/2013;05/12/2017;170.25;;example text;160.23;lorem ipsum;;lorem ipsum;yes;cladribine;;15/05/1983;15/05/1983;15/05/1983;adverse_event;;16/10/2019;12/05/2017;170.25;example content;yes;no;no;yes;;no;no;yes;yes;yes;example textPREFIX_CLWJS/1;19/02/2013;yes;;no;yes;yes;no;yes;yes;;yes;no;yes;yes;no;12/05/2017;160.23;yes;;example content;16/10/2019;;05/12/2017;12/05/2017;no;no;160.23;160.23;yes;no;no;no;no;no;16/10/2019;7.78;non-binary;no;yes;no;8.96;15.23;no;SPMS;16/10/2019;19/02/2013;16/10/2019;160.23;15.23;;7.78;example text;160.23;lorem ipsum;yes;alemtuzumab;example text;16/10/2019;05/12/2017;19/02/2013;;yes;12/05/2017;16/10/2019;;;yes;no;yes;yes;no;;no;no;yes;no;PREFIX_BFNTK/1;;no;no;no;yes;no;yes;yes;yes;no;yes;yes;yes;yes;yes;15/05/1983;7.78;yes;15/05/1983;;15/05/1983;no;15/05/1983;16/10/2019;yes;yes;;15.23;yes;yes;no;yes;no;no;12/05/2017;1.236;non-binary;no;no;no;170.25;15.23;yes;;15/05/1983;05/12/2017;05/12/2017;7.78;7.78;example content;160.23;example text;160.23;example text;no;ocrelizumab;example content;15/05/1983;05/12/2017;19/02/2013;onset_covid;no;12/05/2017;15/05/1983;1.236;example text;yes;no;yes;no;;yes;no;no;yes;yes;example content;15/05/1983;yes;no;no;yes;yes;yes;yes;yes;no;no;no;no;no;yes;19/02/2013;15.23;no;15/05/1983;example content;16/10/2019;yes;15/05/1983;16/10/2019;no;no;7.78;1.236;no;no;yes;no;;yes;16/10/2019;8.96;non-binary;;no;no;170.25;8.96;no;CIS;;16/10/2019;19/02/2013;8.96;15.23;example content;7.78;lorem ipsum;170.25;lorem ipsum;yes;natalizumab;lorem ipsum;;;19/02/2013;pregnancy;no;;12/05/2017;8.96;example content;no;yes;;yes;yes;no;yes;no;yes;yes;example contentPREFIX_HGJLE/1;16/10/2019;no;yes;yes;yes;no;yes;no;no;;no;yes;;no;yes;;170.25;yes;19/02/2013;example text;05/12/2017;no;05/12/2017;19/02/2013;yes;;1.236;15.23;no;yes;no;yes;yes;yes;19/02/2013;170.25;male;no;yes;yes;170.25;15.23;no;;05/12/2017;19/02/2013;16/10/2019;8.96;15.23;example text;160.23;;15.23;example text;yes;siponimod;example content;19/02/2013;05/12/2017;16/10/2019;lack_efficacy;no;15/05/1983;16/10/2019;;lorem ipsum;yes;yes;no;yes;no;yes;yes;;no;;example textPREFIX_YTVSA/1;15/05/1983;no;;yes;yes;yes;no;no;no;no;yes;no;no;;yes;19/02/2013;7.78;no;16/10/2019;lorem ipsum;05/12/2017;yes;;16/10/2019;no;no;7.78;170.25;no;yes;yes;no;not_applicable;;16/10/2019;160.23;female;no;no;no;15.23;170.25;yes;CIS;05/12/2017;05/12/2017;16/10/2019;;7.78;;7.78;example text;7.78;example content;no;siponimod;example content;19/02/2013;05/12/2017;19/02/2013;adverse_event;yes;12/05/2017;19/02/2013;7.78;example content;yes;no;yes;no;no;;;yes;yes;yes;lorem ipsumPREFIX_BUFLP/1;19/02/2013;no;yes;;yes;no;no;no;yes;yes;yes;no;no;yes;yes;12/05/2017;7.78;no;16/10/2019;example content;15/05/1983;yes;15/05/1983;15/05/1983;yes;yes;170.25;170.25;no;no;yes;no;not_applicable;no;15/05/1983;170.25;non-binary;no;yes;;1.236;15.23;yes;CIS;19/02/2013;;19/02/2013;170.25;160.23;example text;160.23;example text;7.78;example content;no;alemtuzumab;example text;;15/05/1983;16/10/2019;lack_efficacy;no;15/05/1983;15/05/1983;1.236;lorem ipsum;yes;yes;yes;no;yes;yes;no;;yes;yes;example contentPREFIX_SMXYX/1;19/02/2013;;no;yes;yes;no;yes;yes;no;no;yes;no;yes;no;yes;15/05/1983;1.236;yes;19/02/2013;example content;;no;16/10/2019;16/10/2019;yes;yes;170.25;170.25;no;yes;no;yes;no;no;16/10/2019;1.236;male;no;yes;no;1.236;15.23;no;PPMS;;16/10/2019;16/10/2019;170.25;160.23;lorem ipsum;160.23;lorem ipsum;15.23;;yes;teriflunomide;example content;16/10/2019;19/02/2013;05/12/2017;adverse_event;no;19/02/2013;15/05/1983;7.78;example text;no;no;;;;yes;no;yes;;no;lorem ipsumPREFIX_VYPFT/1;19/02/2013;yes;no;;no;yes;no;no;yes;no;yes;yes;no;yes;no;16/10/2019;8.96;no;16/10/2019;lorem ipsum;15/05/1983;yes;15/05/1983;15/05/1983;no;yes;15.23;8.96;yes;yes;yes;yes;no;no;19/02/2013;170.25;;yes;yes;no;170.25;1.236;no;not_sure;16/10/2019;19/02/2013;15/05/1983;8.96;7.78;lorem ipsum;;example text;8.96;example text;never_treated;rituximab;example text;15/05/1983;15/05/1983;;;no;16/10/2019;16/10/2019;170.25;example content;yes;no;yes;no;no;yes;no;yes;;yes;example text;15/05/1983;no;yes;yes;no;yes;;yes;no;yes;no;yes;yes;no;yes;19/02/2013;170.25;no;16/10/2019;lorem ipsum;15/05/1983;no;15/05/1983;12/05/2017;no;yes;15.23;1.236;no;yes;no;yes;;yes;12/05/2017;8.96;female;no;no;yes;160.23;1.236;no;not_sure;;16/10/2019;05/12/2017;15.23;160.23;example content;8.96;example content;1.236;example content;never_treated;glatiramer;example content;19/02/2013;15/05/1983;;adverse_event;no;12/05/2017;15/05/1983;8.96;example text;yes;;no;yes;yes;;no;no;yes;no;lorem ipsumPREFIX_VDFVT/1;;no;yes;no;no;;no;;;yes;yes;no;yes;no;no;15/05/1983;170.25;yes;16/10/2019;example content;;;19/02/2013;19/02/2013;no;no;160.23;15.23;no;no;no;yes;not_applicable;yes;15/05/1983;1.236;non-binary;yes;yes;yes;1.236;7.78;no;not_sure;;05/12/2017;;170.25;160.23;example text;170.25;example content;1.236;lorem ipsum;yes;interferons;;16/10/2019;19/02/2013;16/10/2019;lack_efficacy;no;19/02/2013;19/02/2013;7.78;example content;no;yes;no;yes;;no;;no;yes;no;lorem ipsumPREFIX_IQRAM/1;15/05/1983;no;yes;no;yes;no;yes;yes;no;yes;;no;yes;no;yes;16/10/2019;15.23;yes;16/10/2019;lorem ipsum;;;19/02/2013;15/05/1983;no;yes;170.25;160.23;no;yes;yes;yes;not_applicable;;15/05/1983;160.23;female;yes;yes;no;170.25;7.78;no;not_sure;;05/12/2017;;8.96;7.78;;160.23;example content;1.236;lorem ipsum;no;rituximab;;15/05/1983;19/02/2013;19/02/2013;pregnancy;yes;12/05/2017;16/10/2019;7.78;lorem ipsum;no;no;;no;yes;;no;yes;yes;yes;example textPREFIX_ZSDQV/1;15/05/1983;;yes;no;no;yes;;no;yes;yes;no;yes;no;no;no;15/05/1983;;yes;15/05/1983;example content;16/10/2019;yes;05/12/2017;19/02/2013;yes;yes;8.96;1.236;yes;no;no;yes;yes;yes;12/05/2017;170.25;female;no;yes;no;170.25;1.236;no;;05/12/2017;15/05/1983;05/12/2017;15.23;8.96;lorem ipsum;;example text;8.96;example content;never_treated;alemtuzumab;lorem ipsum;05/12/2017;19/02/2013;16/10/2019;patient_decision;no;12/05/2017;12/05/2017;8.96;example content;yes;no;yes;no;yes;no;no;;yes;no;example textPREFIX_MXLXA/1;16/10/2019;yes;no;;;yes;;yes;no;yes;yes;yes;;no;yes;16/10/2019;15.23;yes;15/05/1983;example content;15/05/1983;yes;15/05/1983;;yes;no;15.23;160.23;yes;no;no;no;yes;yes;16/10/2019;8.96;male;;yes;yes;;160.23;yes;SPMS;05/12/2017;05/12/2017;05/12/2017;15.23;;;7.78;;7.78;;no;;example text;19/02/2013;;05/12/2017;patient_decision;yes;19/02/2013;12/05/2017;160.23;example content;no;yes;no;;no;no;yes;no;no;yes;lorem ipsumPREFIX_KBXHP/1;16/10/2019;no;;yes;;no;yes;yes;no;no;yes;no;no;yes;no;12/05/2017;7.78;no;15/05/1983;;;yes;19/02/2013;16/10/2019;no;no;8.96;8.96;no;;yes;yes;no;no;16/10/2019;;male;yes;no;yes;;15.23;no;CIS;16/10/2019;15/05/1983;05/12/2017;;;example text;;example text;170.25;lorem ipsum;;fingolimod;lorem ipsum;05/12/2017;16/10/2019;19/02/2013;;yes;15/05/1983;;170.25;;yes;no;yes;no;yes;;yes;yes;no;no;PREFIX_PERLG/1;15/05/1983;no;no;no;no;no;yes;yes;yes;no;no;yes;;yes;no;12/05/2017;8.96;no;16/10/2019;example content;05/12/2017;no;16/10/2019;16/10/2019;yes;no;1.236;8.96;yes;no;no;yes;yes;no;15/05/1983;160.23;female;no;yes;;1.236;;no;RRMS;16/10/2019;19/02/2013;15/05/1983;1.236;160.23;lorem ipsum;7.78;lorem ipsum;1.236;lorem ipsum;no;fingolimod;example content;;16/10/2019;19/02/2013;patient_decision;no;19/02/2013;16/10/2019;1.236;example text;yes;yes;yes;yes;no;yes;no;yes;no;yes;PREFIX_AVSQI/1;19/02/2013;no;no;no;no;yes;;no;yes;no;no;;yes;no;no;19/02/2013;170.25;;16/10/2019;example content;16/10/2019;no;19/02/2013;19/02/2013;no;yes;1.236;15.23;no;yes;no;yes;not_applicable;no;19/02/2013;7.78;female;;yes;yes;1.236;8.96;no;RRMS;15/05/1983;16/10/2019;05/12/2017;170.25;7.78;example text;15.23;example text;7.78;example content;yes;interferons;lorem ipsum;19/02/2013;05/12/2017;16/10/2019;adverse_event;yes;;16/10/2019;7.78;example content;no;no;no;no;;no;yes;yes;yes;no;example contentPREFIX_UQRID/1;19/02/2013;yes;no;no;yes;no;no;no;no;no;no;no;;yes;;16/10/2019;15.23;;15/05/1983;lorem ipsum;15/05/1983;yes;16/10/2019;19/02/2013;yes;no;170.25;8.96;yes;yes;yes;yes;not_applicable;no;15/05/1983;8.96;;yes;yes;yes;;7.78;no;SPMS;;;05/12/2017;7.78;1.236;example content;15.23;lorem ipsum;15.23;example content;no;;lorem ipsum;05/12/2017;16/10/2019;05/12/2017;lack_efficacy;no;19/02/2013;16/10/2019;160.23;lorem ipsum;yes;no;no;yes;no;no;no;yes;yes;no;example textPREFIX_NRBSX/1;15/05/1983;;yes;no;no;;;yes;no;yes;;no;yes;yes;;16/10/2019;160.23;no;15/05/1983;lorem ipsum;19/02/2013;yes;19/02/2013;15/05/1983;no;no;170.25;170.25;yes;;yes;yes;no;yes;15/05/1983;8.96;male;yes;yes;no;15.23;1.236;yes;PPMS;;;15/05/1983;;160.23;;15.23;example content;170.25;;never_treated;natalizumab;example text;16/10/2019;19/02/2013;16/10/2019;onset_covid;no;12/05/2017;15/05/1983;1.236;lorem ipsum;no;no;no;yes;yes;;no;no;no;no;lorem ipsumPREFIX_NBDGA/1;16/10/2019;no;;yes;no;no;yes;no;no;yes;;yes;yes;yes;no;15/05/1983;15.23;yes;16/10/2019;example text;19/02/2013;yes;15/05/1983;12/05/2017;;yes;1.236;8.96;;no;no;yes;yes;no;15/05/1983;8.96;female;yes;no;no;8.96;160.23;no;not_sure;16/10/2019;05/12/2017;05/12/2017;15.23;;;8.96;example text;1.236;example text;no;teriflunomide;lorem ipsum;16/10/2019;16/10/2019;19/02/2013;patient_decision;no;15/05/1983;16/10/2019;15.23;example text;no;yes;;yes;yes;no;yes;no;no;yes;lorem ipsumPREFIX_TQKVI/1;;yes;yes;;no;no;no;no;no;yes;;no;no;no;no;15/05/1983;160.23;no;16/10/2019;example text;16/10/2019;no;15/05/1983;12/05/2017;yes;yes;170.25;;;yes;yes;yes;yes;yes;15/05/1983;170.25;non-binary;no;yes;no;170.25;160.23;yes;RRMS;05/12/2017;16/10/2019;15/05/1983;;1.236;example text;1.236;example text;8.96;example content;yes;siponimod;example text;;05/12/2017;05/12/2017;onset_covid;yes;12/05/2017;15/05/1983;1.236;example content;;no;no;yes;yes;;yes;yes;no;no;example contentPREFIX_CKJFQ/1;05/12/2017;no;no;no;yes;yes;no;yes;yes;no;yes;yes;yes;;yes;16/10/2019;1.236;no;05/12/2017;lorem ipsum;15/05/1983;no;19/02/2013;19/02/2013;;yes;15.23;1.236;;yes;yes;no;;yes;12/05/2017;8.96;non-binary;yes;yes;no;15.23;;no;PPMS;05/12/2017;;16/10/2019;160.23;8.96;;1.236;example content;170.25;example text;yes;glatiramer;example content;;15/05/1983;;lack_efficacy;no;15/05/1983;15/05/1983;1.236;example text;no;no;;yes;yes;no;;yes;yes;yes;example content